About the Editor:
Stuart A. Montgomery, MD, FRCP, is Professor of Psychiatry at Imperial College of Medicine, University of London. He has worked for many years on identifying, measuring and elucidating the underlying mechanisms of depression and anxiety disorders. Prof. Montgomery has served as a Consultant for and is on the speakers or advisory boards of Lundbeck, Wyeth, GlaxoSmithKline, Pfizer and Roche. He is an editor of European Neuropsychopharmacology and International Clinical Psychopharmacology.